miR-103 promotes endothelial maladaptation by targeting lncWDR59

Lucia Natarelli, Andreas Schober(German Centre for Cardiovascular Research), Gergely Csaba(Ludwig-Maximilians-Universität München), Ralf Zimmer(Leibniz-Institute for Food Systems Biology at the Technical University of Munich), Claudia Geißler(Ludwig-Maximilians-Universität München), Petra Hartmann(Ludwig-Maximilians-Universität München), Andrea Di Francesco(Emcore (United States)), Mengyu Zhu(Ludwig-Maximilians-Universität München), Yuanyuan Wei(Harbin Medical University)
Nature Communications
July 2, 2018
10.1038/s41467-018-05065-z
Cited by 67

Related Papers

A time to fast
|Science|2018|516
Nicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice
|Cell Metabolism|2018|332
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
|The Lancet|2022|310
Lipoprotein-Derived Lysophosphatidic Acid Promotes Atherosclerosis by Releasing CXCL1 from the Endothelium
|Cell Metabolism|2011|219
Restoration of energy homeostasis by SIRT6 extends healthy lifespan
|Nature Communications|2021|196